Short Interest in Cocrystal Pharma, Inc. (NASDAQ:COCP) Grows By 150.0%

Cocrystal Pharma, Inc. (NASDAQ:COCP) saw a large growth in short interest in December. As of December 15th, there was short interest totalling 17,500 shares, a growth of 150.0% from the November 30th total of 7,000 shares. Based on an average daily volume of 24,300 shares, the short-interest ratio is presently 0.7 days. Currently, 0.3% of the company’s stock are short sold.

Cocrystal Pharma Stock Performance

Shares of Cocrystal Pharma stock opened at $2.48 on Friday. The business has a 50-day simple moving average of $2.01 and a 200-day simple moving average of $2.02. Cocrystal Pharma has a one year low of $1.33 and a one year high of $3.10. The company has a market cap of $25.23 million, a PE ratio of -1.34 and a beta of 1.52.

Cocrystal Pharma Company Profile

Cocrystal Pharma, Inc, a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections.